Results of the analysis of 399 elderly patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL) and treated with CHOP or R-CHOP as of April 2001.
| . | CHOP . | R-CHOP . | p value . |
|---|---|---|---|
| Number of patients | 197 | 202 | - |
| CR plus CRu | 126 (64%) | 156 (77%) | < 0.01 |
| Number of events | 110 (56%) | 77 (38%) | = 0.0002 |
| 18-months event-free survival | 43% (± 8%) | 62% (± 8%) | = 0.00012 |
| 2-year overall survival | 61% (± 8%) | 73% (± 8%) | < 0.01 |
| . | CHOP . | R-CHOP . | p value . |
|---|---|---|---|
| Number of patients | 197 | 202 | - |
| CR plus CRu | 126 (64%) | 156 (77%) | < 0.01 |
| Number of events | 110 (56%) | 77 (38%) | = 0.0002 |
| 18-months event-free survival | 43% (± 8%) | 62% (± 8%) | = 0.00012 |
| 2-year overall survival | 61% (± 8%) | 73% (± 8%) | < 0.01 |